GSK logo linking to the homepage Menu Ruben, a senior scientist working in the tuberculosis imaging laboratory at Tres Cantos, Madrid Behind the science TB: uniting scientists to tackle one of the world’s biggest killers Herpes zoster virus of shingles Press releases 02 October 2018 GSK updates policy for working with healthcare professionals 02 October 2018 Positive results from Harmony Outcomes study of albiglutide published in The Lancet 25 September 2018 GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults in phase II study View all press releases London 1,538.60 +6.60 Share price at 16:56 LSE price updated every 15 minutes. Timezone BST NYSE 40.18 +0.13 Share price at 13:57 NYSE price updated every 20 minutes. Timezone EST Tweets from GSK GSK @GSK It’s been an exciting week for global health. Thank you to all our hosts, co-hosts and partners we’ve spoken with during our time at #UNGA. Until next time!👋@FightPovertyy@savechildrenukk@weffhsBCand B about 2 days ago GSK @GSK There are currently 1.8m children under 15 living with #HIV. Through @ViiVHC we are working with partners to accelerate the availability of optimal HIV treatments. about 3 days ago GSK @GSK #ICYMI: The breakthrough interim data announced this week from our TB clinical trial were made possible thanks to our partnership with @aerasglobaltb #endTB about 3 days ago Follow us on Twitter Find out more Our products We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to making our products available to those who need them Health for all Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world. GSK Quick links Behind the science About us Products Careers Investors Media Research Responsibility Legal Terms of use Cookie policy Privacy Notice Modern Slavery Act statement 2017 PDF - 199.6KB Accessibility Sitemap Accessibility Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business © 2001-2018 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.